ADJUVANTS IN ANTI-CANCER CHEMOTHERAPY
    6.
    发明公开
    ADJUVANTS IN ANTI-CANCER CHEMOTHERAPY 有权
    ADJUVANZIEN IN DER CHEMOTHERAPIE GEGEN KREBS

    公开(公告)号:EP3033078A1

    公开(公告)日:2016-06-22

    申请号:EP14750606.7

    申请日:2014-08-05

    IPC分类号: A61K31/357 A61K45/06

    摘要: The present invention provides a 1,2,4-trioxane or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof for use as an adjuvant for a tyrosine kinase inhibitor to enhance the activity of said tyrosine kinase inhibitor in a method for the treatment of a patient suffering from cancer, a pharmaceutical composition comprising a tyrosine kinase inhibitor as an active ingredient and said 1,2,4-trioxane adjuvant or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof in an amount sufficient to enhance the activity of the tyrosine kinase inhibitor, preferably for use in a method for the treatment of cancer.

    摘要翻译: 本发明提供了一种1,2,4-三恶烷或其药学上可接受的盐,酯,溶剂化物,互变异构体或立体异构体,用作酪氨酸激酶抑制剂的佐剂,以增强所述酪氨酸激酶抑制剂的活性 治疗患有癌症的患者,包含酪氨酸激酶抑制剂作为活性成分的药物组合物和所述1,2,4-三恶烷佐剂或其药学上可接受的盐,酯,溶剂合物,互变异构体或立体异构体,其量足以增强 酪氨酸激酶抑制剂的活性,优选用于治疗癌症的方法。